Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 6Polycystic Ovary Syndrome 5Obesity 5Motor Activity 3Ovarian Diseases 2Ovarian Cysts 2Neoplasms 2Hereditary Breast and Ovarian Cancer Syndrome 2Feeding Behavior 2Cardiovascular Diseases 2Thyroid Neoplasms 1Thrombocythemia, Essential 1Smoldering Multiple Myeloma 1Primary Myelofibrosis 1Polycythemia Vera 1Overweight 1Neuroendocrine Tumors 1Myeloproliferative Disorders 1Multiple Myeloma 1Multiple Endocrine Neoplasia Type 1 1Monoclonal Gammopathy of Undetermined Significance 1Intermittent Fasting 1Inflammation 1Growth Hormone-Secreting Pituitary Adenoma 1Fibrosis 1Carcinoma, Hepatocellular 1

Interventions

Sorafenib 131lenvatinib 115Bevacizumab 88Radiosurgery 69atezolizumab 55sintilimab 54Nivolumab 51durvalumab 43Hepatectomy 43Fluorouracil 42apatinib 41Oxaliplatin 41camrelizumab 38Radiofrequency Ablation 38pembrolizumab 36Radiotherapy 36tislelizumab 35Leucovorin 31Magnetic Resonance Spectroscopy 30Immune Checkpoint Inhibitors 28Doxorubicin 28Folfox protocol 26tremelimumab 25regorafenib 25Cisplatin 20spartalizumab 19donafenib 19Gemcitabine 19Cyclophosphamide 19toripalimab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Hepatocellular × Diet, Mediterranean × Clear all
NCT03853928 2019-02-27

Probiotics in the Prevention of Hepatocellular Carcinoma in Cirrhosis

Austral University, Argentina

Phase NA Unknown
280 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡